Big Week for Big Biotech ETF

This is how strong biotechnology exchange traded funds have been in 2014: The iShares Nasdaq Biotechnology ETF (NYSEArca: IBB) is the worst performer among the five major biotech ETFs with a year-to-date gain of “just” 8.3%. Do not cry for IBB. It is by far the largest biotech ETF by assets with...